Featured Research

from universities, journals, and other organizations

Research points new way to possible Alzheimer’s vaccine

Date:
September 26, 2011
Source:
Georgia Health Sciences University
Summary:
An accomplice to the protein that causes plaque buildup in Alzheimer's disease is the focus of a potential new treatment, according to research.

An accomplice to the protein that causes plaque buildup in Alzheimer's disease is the focus of a potential new treatment, according to research by Georgia Health Sciences University graduate student, Scott Webster (pictured).
Credit: Phil Jones, Georgia Health Sciences University photographer

An accomplice to the protein that causes plaque buildup in Alzheimer's disease is the focus of a potential new treatment, according to research by a Georgia Health Sciences University graduate student.

In Alzheimer's, the amyloid protein can accumulate in the brain instead of being eliminated by the body's natural defenses, nestling between the neurons and forming impassable plaques.

Amyloid and the way it gets there could be targets for a new vaccine.

"RAGE, or receptor for advanced glycation endproducts, proteins bind to amyloid and transport it into the brain," said Scott Webster, a fifth-year graduate student who is studying the disease in the lab of Dr. Alvin Terry, Professor of Pharmacology and Toxicology. Research has shown that RAGE may also contribute to the inflammation and damage that amyloid causes to the brain's nerve cells.

Webster is researching a vaccine that targets RAGE and amyloid by using the body's own immune system to protect against their over-production and eventual build-up. His work has earned him the 2011 Darrell W. Brann Scholarship in Neuroscience, a $1,000 award honoring an outstanding graduate student on campus working in neuroscience.

"Unfortunately, all of the vaccines for Alzheimer's that have been through clinical trials have failed," he said. "Part of the reason why could be that they're just not comprehensive enough. Most only target amyloid. Our hope is that by taking a more encompassing approach, we will be more effective. So far, that's exactly what we're seeing in our experiments."

Other vaccines also have multiple side effects, including swelling of the brain. Webster hopes that targeting the RAGE protein and changing how the vaccine is administered will minimize inflammatory side effects.

Another benefit is that the vaccine can be administered orally, since it does not require an adjuvant, which is added to vaccines to enhance the immune response. The digestive tract is one of the body's largest repositories of human flora, microorganisms that are key to the immune system.

"That's a relatively new idea," Webster said. "By using the immune system that's endogenous to our gut, we can skew the body's response away from the inflammatory and toward a more robust antibody response, bypassing some of the side effects."

Early results have shown improved cognition and memory in animal models of Alzheimer's, something Webster considers a sort of personal crusade.

"I have watched a close family friend suffer from the disease and saw how devastating it was," he said. "The family is caring for this person and yet the person doesn't even remember who his own family is. It's a heartbreaking process to watch."

Even with promising results, he cautioned of unknowns about the potential vaccine.

"We need to move on to larger animal studies. We have a lot we still don't know about the vaccine itself. For example, we know that amyloid and RAGE bind together, but we don't know why the binding creates such a stable complex. We have these end points, but we still don't know some of the basic science that needs to be known so that we can push ahead."

In addition to the Brann Scholarship, Webster's research has earned him an invitation to the St. Jude National Graduate Student Symposium and the National Institutes of Health National Graduate Student Research Conference. He is also a two-time recipient of the Lowell Greenbaum Award for Research Excellence in Pharmacology.


Story Source:

The above story is based on materials provided by Georgia Health Sciences University. Note: Materials may be edited for content and length.


Cite This Page:

Georgia Health Sciences University. "Research points new way to possible Alzheimer’s vaccine." ScienceDaily. ScienceDaily, 26 September 2011. <www.sciencedaily.com/releases/2011/09/110926104609.htm>.
Georgia Health Sciences University. (2011, September 26). Research points new way to possible Alzheimer’s vaccine. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2011/09/110926104609.htm
Georgia Health Sciences University. "Research points new way to possible Alzheimer’s vaccine." ScienceDaily. www.sciencedaily.com/releases/2011/09/110926104609.htm (accessed April 18, 2014).

Share This



More Health & Medicine News

Friday, April 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com
Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins